Press Releases
TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities
Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer
TCG Labs Soleil Raises Inaugural $400 Million Fund
